Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients

Status unconfirmed · Early Phase 1

Conditions studied: Obesity, Morbid, Preeclampsia

In brief

To determine if the use of impedance cardiography can identify appropriate medications for use in treating morbidly obese patients to decrease the risk of preeclampsia.

Key facts

Study ID

NCT03105661

Run by

University of Tennessee Graduate School of Medicine

People needed

400

Starts

2017-04-04

Expected to finish

2020-03-04

Last updated by the study team

2019-02-22

Who can join

Age: 18 and older, up to 51. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant patients 18-51 years old,
• Less than 20 weeks gestation with Morbid Obesity (BMI >/= 40)
• Not on antihypertensive medications

You may not qualify if…

• Patients with an allergy to antihypertensive medication or contraindication for their usage such as certain cardiac or neurologic disorder during pregnancy
• Patients who have a blood pressure 140/90 or greater

Where it is running

• University of Tennessee Medical Center — Knoxville, Tennessee, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.